Oncology Institute
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $136,564 | $119,802 | $104,406 | $100,267 |
Gross Profit | 18,920 | 17,501 | 17,249 | 14,636 |
EBITDA | -12,861 | -9,406 | -12,231 | -10,307 |
EBIT | -14,584 | -11,211 | -14,015 | -12,014 |
Net Income | -16,504 | -17,009 | -19,585 | -13,182 |
Net Change In Cash | 136,564 | 119,802 | 104,406 | 100,267 |
Free Cash Flow | -13,234 | -11,410 | -5,316 | 2,431 |
Cash | 27,658 | 30,292 | 39,739 | 49,669 |
Basic Shares | 974,747 | 932,036 | 77,099 | 75,655 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $393,412 | $324,239 | $252,483 | $203,003 |
Gross Profit | 53,997 | 59,573 | 52,093 | 40,848 |
EBITDA | -53,831 | -54,278 | -67,596 | -42,041 |
EBIT | -60,118 | -60,151 | -72,007 | -45,382 |
Net Income | -64,663 | -83,068 | 152 | -10,927 |
Net Change In Cash | 393,412 | 324,239 | 252,483 | 203,003 |
Cost of Revenue | -101,164 | 891 | ||
Free Cash Flow | -30,327 | -40,882 | -67,285 | -35,727 |
Cash | 49,669 | 33,488 | 14,010 | 114,299 |
Basic Shares | 75,043 | 73,748 | 80,605 | 66,230 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.20 |
